日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The Nucleocapsid Protein of SARS-CoV-2, Combined with ODN-39M, Is a Potential Component for an Intranasal Bivalent Vaccine with Broader Functionality.

SARS-CoV-2 的核衣壳蛋白与 ODN-39M 结合,是一种具有更广泛功能的鼻内二价疫苗的潜在成分

Lobaina Yadira, Chen Rong, Suzarte Edith, Ai Panchao, Huerta Vivian, Musacchio Alexis, Silva Ricardo, Tan Changyuan, Martín Alejandro, Lazo Laura, Guillén-Nieto Gerardo, Yang Ke, Perera Yasser, Hermida Lisset

A Nasal Vaccine Candidate, Containing Three Antigenic Regions from SARS-CoV-2, to Induce a Broader Response

一种含有SARS-CoV-2三个抗原区域的鼻腔疫苗候选物,旨在诱导更广泛的免疫反应

Lobaina, Yadira; Chen, Rong; Suzarte, Edith; Ai, Panchao; Musacchio, Alexis; Lan, Yaqin; Chinea, Glay; Tan, Changyuan; Silva, Ricardo; Guillen, Gerardo; Yang, Ke; Li, Wen; Perera, Yasser; Hermida, Lisset